Form 4: Medpace Holdings Director Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Ashley M. Keating, a director at Medpace Holdings, exercised stock options and sold shares on February 26, 2024, according to a Form 4 filing with the SEC.
Summary
- On February 26, 2024, Ashley M. Keating, a director of Medpace Holdings, Inc., executed transactions involving the company's stock.
- Keating exercised stock options to acquire 500 shares of common stock at a price of $54.99 per share.
- Following the exercise of options, Keating sold 246 shares at $403.894 per share and 254 shares at $404.68 per share.
- After these transactions, Keating directly owns 0 shares of common stock and 972 derivative securities (stock options).
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company director, indicating neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions and provides transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| 05/14/2020 | Stock option vested in full |
| 05/17/2026 | Expiration date of stock options |
| 02/26/2024 | Date of earliest transaction: stock option exercise and stock sales |
| 02/28/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.